Eurobio-Scientific SA (E8TN) Financial Statements
Eurobio-Scientific SA Financial Overview
Eurobio-Scientific SA's market cap is currently $258.39M. The company's EPS TTM is $0.70; its P/E ratio is 37.57; Eurobio-Scientific SA is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 169.00M | $ 154.95M | $ 130.65M | $ 152.61M | $ 184.71M |
| Gross Profit | $ 68.40M | $ 71.95M | $ 57.49M | $ 65.04M | $ 97.44M |
| Operating Income | $ 15.45M | $ 13.40M | $ 10.14M | $ 30.87M | $ 71.99M |
| EBITDA | $ 32.39M | $ 29.05M | $ 24.55M | $ 40.20M | $ 79.63M |
| Net Income | $ 4.87M | $ 4.00M | $ 4.83M | $ 24.94M | $ 60.54M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 20.66M | $ 23.07M | $ 89.03M | $ 85.94M | $ 102.39M |
| Total Assets | $ 256.76M | $ 257.17M | $ 316.33M | $ 330.42M | $ 209.22M |
| Total Debt | $ 16.02M | $ 34.05M | $ 100.66M | $ 113.60M | $ 15.68M |
| Net Debt | $ -4.30M | $ 12.28M | $ 52.03M | $ 66.11M | $ -77.24M |
| Total Liabilities | $ 72.83M | $ 78.31M | $ 141.16M | $ 157.75M | $ 49.00M |
| Stockholders' Equity | $ 183.92M | $ 178.85M | $ 175.17M | $ 172.34M | $ 159.91M |
| Cash Flow | |||||
| Free Cash Flow | $ 6.28M | $ 13.45M | $ 22.71M | $ 39.01M | $ 63.61M |
| Operating Cash Flow | $ 18.85M | $ 16.70M | $ 26.77M | $ 43.07M | $ 65.92M |
| Investing Cash Flow | $ -12.89M | $ -10.74M | $ -318.00K | $ -141.76M | $ -5.47M |
| Financing Cash Flow | $ -8.16M | $ -72.09M | $ -23.50M | $ 82.31M | $ -23.75M |
Currency in EUR